Keyphrases
TP53 mutation
100%
Tumor Protein p53 (TP53)
66%
Ovarian Cancer
58%
Mtdh
50%
Conventional Chemotherapy
50%
Taxanes
50%
Serous Ovarian Carcinoma
50%
Metadherin
50%
Wobble Position
50%
BI2536
37%
Tumor
25%
Chemoresistance
25%
Tumor Suppressor
25%
Chemotherapy
16%
Serous Ovarian Tumor
16%
Oncogene
16%
Poor Prognosis
16%
Cancer Genome Atlas
16%
Progression-free Survival
16%
Drug Resistance
16%
Response to Chemotherapy
16%
Biological Markers
16%
Ovarian Cancer Cells
16%
Tumor Chemoresistance
16%
Patient Outcomes
16%
Drug Response
16%
Gynecologic Malignancies
16%
Patient Response
16%
CCR4-NOT Complex
16%
Pathological Pathways
16%
Mutant p53 Protein
16%
Ovarian Cancer Patients
16%
Molecular Pathways
16%
Tumor Progression
16%
Gain-of-function mutation
16%
Drug Intervention
16%
APOBEC3A
13%
Polo-like Kinase Inhibitor
12%
Hormonal Cycle
12%
Metaphase I
11%
Deadenylation
11%
Mutator
9%
Serous Ovarian Cancer
8%
Protein Expression Profile
8%
University of Iowa
8%
Confidence Interval
8%
Protein Function
8%
Ovarian Tumor
8%
Cancer Cell Models
8%
P53 Protein
8%
Biochemistry, Genetics and Molecular Biology
Inosine
100%
RNA
100%
Messenger RNA
91%
MicroRNA
58%
Histone Deacetylase
50%
Follicular Fluid
50%
CCR4
50%
Transcription
50%
Cancer Cell
50%
Programmed Cell Death
50%
Cell Death
50%
Codon
50%
Tumor Necrosis Factor
41%
Metaphase
17%
Coding Region
16%
Drug Resistance
16%
Gene Translocation
13%
B Cell
13%
Maturation
12%
mRNA Stability
12%
Oocyte Maturation
12%
PDCD10
12%
Gene Expression
10%
Protein Secondary Structure
8%
Galectin-1
8%
Cell Cycle Checkpoint
8%
Vitamin D-Dependent Calcium-Binding Protein
8%
Codon Usage
8%
Calbindin
8%
Phosphoinositide-Dependent Kinase-1
8%
X-Linked Inhibitory Apoptosis Protein
8%
Chemosensitivity
8%
Sensitization
8%
Translational Efficiency
8%
Medicine and Dentistry
Ovarian Cancer
100%
Drug Resistance
62%
Krukenberg Tumor
57%
Epithelial Cell
50%
Cytidine Deaminase
50%
DNA Damage
42%
Tumor Suppressor Protein
29%
Protein P53
29%
Ovarian Tumor
29%
Neoplasm
29%
The Cancer Genome Atlas
25%
Progression Free Survival
25%
4 (8 Cyclopentyl 7 Ethyl 5,6,7,8 Tetrahydro 5 Methyl 6 Oxo 2 Pteridinylamino) 3 Methoxy N (1 Methyl 4 Piperidinyl)benzamide
21%
Cell Proliferation
21%
Oncogene
16%
Biological Marker
16%
Diseases
16%
Tumor Suppressor Gene
16%
Cancer
16%
Tumor Progression
16%
Drug Response
16%
Gain of Function Mutation
16%
Cell DNA
14%
Mutagenic Agent
14%
PDCD10
12%
Protein Function
12%
Cancer Cell
12%
Protein Expression
12%
Ovarian Cancer Cell Line
12%
Adjuvant Chemotherapy
12%
Recurrence Free Survival
12%
Recurrent Disease
12%
Galectin 1
10%
Wee1
7%
Messenger RNA
7%
Double-Strand DNA Break
7%
Polypeptide
7%
Apolipoprotein B
7%
Western Blot
7%
Quantitative Reverse Transcription Polymerase Chain Reaction
7%
Expression Vector
7%
Gene Expression
7%
Ovulation Induction
7%
